{"title":"Purpura fulminans caused by Streptococcus pneumoniae serotype 23A in a young post-splenectomy man: A case report","authors":"Aya Hamasaki , Tetsuya Yumoto , Shinnosuke Fukushima , Hideharu Hagiya , Bin Chang , Yukihiro Akeda , Takashi Hongo , Kohei Tsukahara , Hiromichi Naito , Atsunori Nakao","doi":"10.1016/j.jiac.2025.102791","DOIUrl":null,"url":null,"abstract":"<div><div>Purpura fulminans is a rare but severe complication of septic shock, often associated with <em>Streptococcus pneumoniae</em> infection in asplenic individuals, with high mortality and limb amputation risk. Although pneumococcal vaccines are available, infections caused by non-vaccine serotypes remain a major concern. A 39-year-old man with a history of splenectomy 18 years prior presented with dyspnea, malaise, and gastrointestinal symptoms for two days. He had never received pneumococcal vaccination following his splenectomy. On arrival, he was hypotensive, tachycardic, and exhibited signs of multi-organ failure with severe coagulopathy. Physical examination revealed widespread cyanosis and purpura. Blood cultures yielded penicillin-susceptible <em>S. pneumoniae</em>, later identified as serotype 23A (Sequence Type 5242), which is not included in currently available vaccines in Japan. Despite prompt intensive care, including broad-spectrum antibiotics, vasopressors, continuous renal replacement therapy, and mechanical ventilation, the patient developed progressive skin necrosis at the distal extremities. Ultimately, he required amputation of all 4 limbs. This case underscores the catastrophic consequences of overwhelming post-splenectomy infection due to a non-vaccine <em>S. pneumoniae</em> serotype in an unvaccinated asplenic adult. Early recognition and aggressive management are essential to save lives, but structured, lifelong pneumococcal vaccination and increased awareness among clinicians and patients remain paramount.</div></div>","PeriodicalId":16103,"journal":{"name":"Journal of Infection and Chemotherapy","volume":"31 10","pages":"Article 102791"},"PeriodicalIF":1.5000,"publicationDate":"2025-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection and Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1341321X25001886","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Purpura fulminans is a rare but severe complication of septic shock, often associated with Streptococcus pneumoniae infection in asplenic individuals, with high mortality and limb amputation risk. Although pneumococcal vaccines are available, infections caused by non-vaccine serotypes remain a major concern. A 39-year-old man with a history of splenectomy 18 years prior presented with dyspnea, malaise, and gastrointestinal symptoms for two days. He had never received pneumococcal vaccination following his splenectomy. On arrival, he was hypotensive, tachycardic, and exhibited signs of multi-organ failure with severe coagulopathy. Physical examination revealed widespread cyanosis and purpura. Blood cultures yielded penicillin-susceptible S. pneumoniae, later identified as serotype 23A (Sequence Type 5242), which is not included in currently available vaccines in Japan. Despite prompt intensive care, including broad-spectrum antibiotics, vasopressors, continuous renal replacement therapy, and mechanical ventilation, the patient developed progressive skin necrosis at the distal extremities. Ultimately, he required amputation of all 4 limbs. This case underscores the catastrophic consequences of overwhelming post-splenectomy infection due to a non-vaccine S. pneumoniae serotype in an unvaccinated asplenic adult. Early recognition and aggressive management are essential to save lives, but structured, lifelong pneumococcal vaccination and increased awareness among clinicians and patients remain paramount.
期刊介绍:
The Journal of Infection and Chemotherapy (JIC) — official journal of the Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases — welcomes original papers, laboratory or clinical, as well as case reports, notes, committee reports, surveillance and guidelines from all parts of the world on all aspects of chemotherapy, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies on animal models and pharmacokinetics, and reports on epidemiology and clinical trials are particularly welcome.